Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total

Not Applicable (1)

P 2 (1)

Trial Status

Completed1

Recruiting1

Unknown1

Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (4)

Showing 4 of 4 trials

NCT04196595Recruiting

Apple Women's Health Study

NCT03830723Phase 2Completed

Personalized Insemination Treatment Study

NCT02634359Not ApplicableUnknownPrimary

Evaluation of EarlySense for Monitoring Ovulation Cycles and Detection of Early Stages of Pregnancy in Home Environment

NCT00767611Withdrawn

Molecular Markers of Human Sperm Function

Showing all 4 trials

Reproduction